vs

Side-by-side financial comparison of NexPoint Real Estate Finance, Inc. (NREF) and SurgePays, Inc. (SURG). Click either name above to swap in a different company.

SurgePays, Inc. is the larger business by last-quarter revenue ($16.2M vs $11.1M, roughly 1.5× NexPoint Real Estate Finance, Inc.). NexPoint Real Estate Finance, Inc. runs the higher net margin — 216.6% vs -85.6%, a 302.3% gap on every dollar of revenue. On growth, SurgePays, Inc. posted the faster year-over-year revenue change (68.7% vs -48.8%).

NexPoint Real Estate Finance, Inc. is a US-based commercial real estate finance firm that offers structured financing solutions for multifamily, office, industrial, and hospitality properties. It focuses on originating, managing and servicing a diversified portfolio of mortgage loans and real estate-related investments to deliver stable risk-adjusted returns to stakeholders.

SurgePays, Inc. is a U.S.-headquartered fintech and telecommunications company focused on serving underbanked and low-income communities across the country. It offers prepaid wireless plans, reloadable debit cards, digital banking solutions, and daily consumer products through a nationwide network of independent local retail partners such as convenience stores.

NREF vs SURG — Head-to-Head

Bigger by revenue
SURG
SURG
1.5× larger
SURG
$16.2M
$11.1M
NREF
Growing faster (revenue YoY)
SURG
SURG
+117.5% gap
SURG
68.7%
-48.8%
NREF
Higher net margin
NREF
NREF
302.3% more per $
NREF
216.6%
-85.6%
SURG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NREF
NREF
SURG
SURG
Revenue
$11.1M
$16.2M
Net Profit
$24.0M
$-13.9M
Gross Margin
-14.8%
Operating Margin
-79.1%
Net Margin
216.6%
-85.6%
Revenue YoY
-48.8%
68.7%
Net Profit YoY
58.7%
30.0%
EPS (diluted)
$0.47
$-0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NREF
NREF
SURG
SURG
Q4 25
$11.1M
$16.2M
Q3 25
$12.5M
$18.7M
Q2 25
$12.1M
$11.5M
Q1 25
$11.5M
$10.6M
Q4 24
$21.7M
$9.6M
Q3 24
$12.5M
$4.8M
Q2 24
$6.7M
$15.1M
Q1 24
$-12.8M
$31.4M
Net Profit
NREF
NREF
SURG
SURG
Q4 25
$24.0M
$-13.9M
Q3 25
$50.9M
$-7.5M
Q2 25
$22.3M
$-7.1M
Q1 25
$26.0M
$-7.6M
Q4 24
$15.2M
$-19.8M
Q3 24
$23.3M
$-14.3M
Q2 24
$12.1M
$-12.9M
Q1 24
$-14.6M
$1.2M
Gross Margin
NREF
NREF
SURG
SURG
Q4 25
-14.8%
Q3 25
-13.9%
Q2 25
-23.0%
Q1 25
-27.8%
Q4 24
-117.0%
Q3 24
-164.2%
Q2 24
-22.8%
Q1 24
26.0%
Operating Margin
NREF
NREF
SURG
SURG
Q4 25
-79.1%
Q3 25
-37.2%
Q2 25
-59.1%
Q1 25
-71.7%
Q4 24
-209.0%
Q3 24
-299.4%
Q2 24
-72.1%
Q1 24
5.6%
Net Margin
NREF
NREF
SURG
SURG
Q4 25
216.6%
-85.6%
Q3 25
407.0%
-40.1%
Q2 25
184.5%
-61.5%
Q1 25
225.6%
-72.2%
Q4 24
69.9%
-206.5%
Q3 24
186.4%
-299.3%
Q2 24
179.7%
-85.3%
Q1 24
114.3%
3.9%
EPS (diluted)
NREF
NREF
SURG
SURG
Q4 25
$0.47
$-0.68
Q3 25
$1.14
$-0.38
Q2 25
$0.54
$-0.36
Q1 25
$0.70
$-0.38
Q4 24
$0.71
$-1.07
Q3 24
$0.74
$-0.73
Q2 24
$0.40
$-0.66
Q1 24
$-0.83
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NREF
NREF
SURG
SURG
Cash + ST InvestmentsLiquidity on hand
$31.1M
$1.7M
Total DebtLower is stronger
$771.2M
$13.3M
Stockholders' EquityBook value
$388.0M
$-15.3M
Total Assets
$5.3B
$8.5M
Debt / EquityLower = less leverage
1.99×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NREF
NREF
SURG
SURG
Q4 25
$31.1M
$1.7M
Q3 25
$17.9M
$2.5M
Q2 25
$9.1M
$4.4M
Q1 25
$19.2M
$5.4M
Q4 24
$3.9M
$11.8M
Q3 24
$34.7M
$23.7M
Q2 24
$4.3M
Q1 24
$13.5M
Total Debt
NREF
NREF
SURG
SURG
Q4 25
$771.2M
$13.3M
Q3 25
$720.9M
$12.0M
Q2 25
$815.6M
$9.6M
Q1 25
$831.5M
$3.6M
Q4 24
$799.3M
$4.0M
Q3 24
$815.5M
$4.4M
Q2 24
$861.0M
$4.8M
Q1 24
$843.3M
$5.2M
Stockholders' Equity
NREF
NREF
SURG
SURG
Q4 25
$388.0M
$-15.3M
Q3 25
$375.4M
$-6.4M
Q2 25
$348.2M
$116.1K
Q1 25
$343.7M
$7.8M
Q4 24
$336.5M
$15.3M
Q3 24
$335.8M
$33.2M
Q2 24
$327.5M
$46.2M
Q1 24
$327.1M
$56.0M
Total Assets
NREF
NREF
SURG
SURG
Q4 25
$5.3B
$8.5M
Q3 25
$5.3B
$14.5M
Q2 25
$5.4B
$15.2M
Q1 25
$5.4B
$15.7M
Q4 24
$5.4B
$24.0M
Q3 24
$5.7B
$41.5M
Q2 24
$6.6B
$56.4M
Q1 24
$7.1B
$69.6M
Debt / Equity
NREF
NREF
SURG
SURG
Q4 25
1.99×
Q3 25
1.92×
Q2 25
2.34×
82.67×
Q1 25
2.42×
0.46×
Q4 24
2.38×
0.26×
Q3 24
2.43×
0.13×
Q2 24
2.63×
0.10×
Q1 24
2.58×
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NREF
NREF
SURG
SURG
Operating Cash FlowLast quarter
$-4.5M
$-3.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
-0.19×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NREF
NREF
SURG
SURG
Q4 25
$-4.5M
$-3.6M
Q3 25
$8.1M
$-4.6M
Q2 25
$3.3M
$-6.1M
Q1 25
$16.0M
$-7.0M
Q4 24
$4.4M
$-7.9M
Q3 24
$14.7M
$-13.3M
Q2 24
$-7.5M
$-4.1M
Q1 24
$17.7M
$4.0M
Cash Conversion
NREF
NREF
SURG
SURG
Q4 25
-0.19×
Q3 25
0.16×
Q2 25
0.15×
Q1 25
0.62×
Q4 24
0.29×
Q3 24
0.63×
Q2 24
-0.62×
Q1 24
3.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons